121P Health-related quality of life (HRQoL) outcomes from CheckMate 77T: Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant NIVO in resectable NSCLC

J. Spicer,M. Provencio Pulla, M. Awad, J. He, S. Lu, F. Tanaka, R. Cornelissen, L.B. Petruzelka, J. Kuzdzal, L. Wu,J-L. Pujol, H. Ito, T-E. Ciuleanu, L.D.O.M. Koch, A. Janssens, S.I. Blum, L. Vo, C. Coronado Erdmann, S. Meadows-Shropshire, T. Cascone

ESMO Open(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要